Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted) (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 833.33 Mn |
| 10 | Amphastar Pharmaceuticals | 937.87 Mn | 647.74 Mn | 93.47 Mn | 44.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.23 Mn |
| Mar 31, 2026 | 46.46 Mn |
| Dec 31, 2025 | 48.22 Mn |
| Sep 30, 2025 | 47.68 Mn |
| Jun 30, 2025 | 48.13 Mn |
| Mar 31, 2025 | 49.89 Mn |
| Dec 31, 2024 | 52.06 Mn |
| Sep 30, 2024 | 51.86 Mn |
| Jun 30, 2024 | 52.05 Mn |
| Mar 31, 2024 | 53.01 Mn |
| Dec 31, 2023 | 53.00 Mn |
| Sep 30, 2023 | 53.92 Mn |
| Jun 30, 2023 | 53.10 Mn |
| Mar 31, 2023 | 51.97 Mn |
| Dec 31, 2022 | 52.43 Mn |
| Sep 30, 2022 | 52.79 Mn |
| Jun 30, 2022 | 53.23 Mn |
| Mar 31, 2022 | 51.98 Mn |
| Dec 31, 2021 | 49.78 Mn |
| Sep 30, 2021 | 50.01 Mn |